Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: AMERISOURCEBERGEN DRUG CORP
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2023-05-26 to 2023-05-30
Current total value of award: $8883.68
Description: 4561060721!QUILLIVANT XR ORAL SUSP 60ML 5MG/ML